|Day Low/High||7.60 / 7.76|
|52 Wk Low/High||5.92 / 8.74|
Rite Aid (RAD) said today that naloxone, a medication used to treat opioid overdoses, is now available at about 440 U.S. Rite Aid pharmacies without a prescription.
Rite Aid announced today that naloxone, a medication that can be used to reverse the effects of an opioid overdose, is now available at more than 440 pharmacies in Kentucky, Ohio, Oregon and Vermont without a prescription,...
Relief over the Federal Reserve's slow-and-steady interest rate plan fueled another day of gains Thursday, pushing the Nasdaq to a record close for the second session in a row.
Stocks hold in the green on Thursday as relief over a patient Federal Reserve fuels market gains.
Rite Aid shares are up Thursday after posting second quarter earnings of $0.03 a share, a penny ahead of forecasts.
Stocks rise Thursday as relief over a patient Federal Reserve fuels market gains.
U.S. stocks rose on Thursday, fueled by the Federal Reserve's decision Wednesday to keep interest rates lower for longer.
Stock futures move higher on Thursday as relief over a patient Federal Reserve fuels market gains for a second day.
Rite Aid (RAD) reported higher-than-anticipated earnings for the 2017 fiscal second quarter, but soft revenue on Thursday morning.
Earnings and economic data are in focus for Thursday, September 22.
U.S. stock futures edge higher after the Federal Reserve leaves interest rates unchanged; a report says Yahoo! may confirm this week a massive data breach of its service.
Rite Aid Corporation (NYSE:RAD) today reported operating results for its second fiscal quarter ended August 27, 2016.
Rite Aid earnings are likely to disappoint if there are no advancements from the FTC on its deal with Walgreens or a divestiture plan for some of its locations.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer isn't fond of how Rite Aid is being managed.
The pharmacy company presents a solid buying opportunity for investors who willing to hold for the long term.
Rite Aid (RAD) is scheduled to release its 2017 fiscal second quarter earnings before Thursday's market open.
The Federal Reserve takes center stage for the week of September 19.
The much-ballyhooed meeting of the Federal Reserve is finally here.
Cramer will be monitoring earnings and the Federal Reserve next week.
Shares of Walgreens have been trapped in no man's land since the company announced the acquisition of Rite Aid. Does it have room to rise?
Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2017 Second Quarter at 7 a.
Greg Nathan, portfolio manager for the FPA U.S. Value Fund, is ignoring the clamor over drug pricing with these choices.
McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.
The Rite Aid Foundation announced today that more than 400 students have been named recipients of Folds of Honor educational scholarships through its KidCents program.
Disappointment over the ECB's inaction and uncertainty over the Fed's rate plans left markets rattled.
Worries that the Federal Reserve will shift from accommodative policies and concerns that the European Central Bank wasn't implementing enough of its own left markets rattled.
Oil stocks surge on EIA data, while Rite Aid and Walgreens continue to push their pending deal forward.